On June 15, 2023, Mind Medicine (MindMed) Inc. announced that the Companyâs annual general meeting of shareholders on June 15, 2023 was convened and adjourned, without any business being conducted, due to lack of the required quorum. The Company added that the meeting would resume with respect to all proposals on June 21, 2023 and would continue to be held virtually via live webcast at www.proxydocs.com/MNMD.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.22 USD | -4.97% | -9.87% | +124.59% |
05-13 | Oppenheimer Adjusts Mind Medicine Price Target to $20 From $29, Maintains Outperform Rating | MT |
05-08 | Transcript : Mind Medicine Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+124.59% | 622M | |
+33.63% | 50.85B | |
-0.09% | 42.82B | |
+49.62% | 42.03B | |
-4.96% | 29.55B | |
+11.18% | 26.11B | |
-21.95% | 19.13B | |
+8.61% | 13.05B | |
+28.31% | 12.16B | |
+24.73% | 12.08B |
- Stock Market
- Equities
- MNMD Stock
- News Mind Medicine (MindMed) Inc.
- Mind Medicine Adjourns Annual General Meeting of Shareholders